Quality of life assessment in patients with Graves' disease and progressive infiltrative ophthalmopathy during combined treatment with methylprednisolone and orbital radiotherapy

Endokrynologia Polska

Volumn 60, Issue 3, 2009, Pages 158-165

  Kulig, Grzegorz ^a   Andrysiak Mamos, Elzbieta ^a   Sowińska Przepiera, Elzbieta ^b   Kulig, Jolanta ^b   Karakiewicz, Beata ^b   Brodowski, Jacek ^b   Robaczyk, Maciej ^c   Homa, Katarzyna ^a   Letkiewicz, Magdalena ^a   Syrenicz, Anhelli ^a  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b Department of Public Health ^*

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Graves' disease; Graves' ophthalmopathy; Methylprednisolone; Orbital radiotherapy; Quality of life

Indexed keywords

METHYLPREDNISOLONE SODIUM SUCCINATE;

ADULT; AGED; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DRUG PULSE THERAPY; EMOTION; ENDOCRINE OPHTHALMOPATHY; FEMALE; FUNCTIONAL ASSESSMENT; GRAVES DISEASE; HUMAN; MALE; MENTAL HEALTH; MULTIPLE CYCLE TREATMENT; OUTCOME ASSESSMENT; PAIN; PHYSICAL ACTIVITY; PROGRESSIVE INFILTRATIVE OPHTHALMOPATHY; QUALITY OF LIFE; RATING SCALE; SCORING SYSTEM; SHORT FORM 36; SOCIAL INTERACTION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; AGED; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; GRAVES OPHTHALMOPATHY; HUMANS; INFUSIONS, INTRAVENOUS; METHYLPREDNISOLONE HEMISUCCINATE; MIDDLE AGED; PULSE THERAPY, DRUG; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 67749116193     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bahn RS, Heufelder AE. Pathogenesis of Graves' ophthalmopathy. N Engl J Med 1993; 7: 481-493.
2. Cawood T, Moriarty P, O'Shea D. Recent developments In thyroid eye disease. BMJ 2004; 329: 385-390. (Pubitemid 39099747)
3. Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000; 21: 168-199. (Pubitemid 32275594)
4. Terwee CB, Gerding MN, Dekker FW et al. Test-retest reliability of the GO-QOL: a disease-specific quality of life questionnaire for patients with Graves' ophtalmopathy. J Clin Epidemiol 1999; 52: 875-884.
5. Gerding M.N, Terwee CB, Dekker FW et al. Quality of life in patients with Graves' ophtalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 1997; 7: 885-889.
6. Park JJ, Sullivan TJ, Mortimer RH et al. Assessing quality of life in Australian patients with Graves' ophtalmopathy. Br J Ophtalmol 2004; 88: 75-78. (Pubitemid 38091368)
7. Elberling TV, Rasmussen AK, Feldt-Rasmussen U et al. Impaired Heath-related quality in Graves' disease. A prospective study. Eur J Endocrinol 2004; 5: 549-555. (Pubitemid 39562508)
8. Donaldson SS, Bagshaw MA, Kriss JP. Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 1976; 118: 276-284.
9. Mourits MP, Prummel MF, Wiersinga WM et al. Clinical activity score as a guide in the management of patient with Graves' ophthalmopathy. Clin Endocrinol 1997; 47: 9-14. (Pubitemid 27313981)
10. Ware JE, Snow KK, Kosiński M et al. SF-36 Health Survey. Manual and interpretation guide, Health Institute, NEMC, Boston 1993.
11. Alonso J, Anto JM, Gonzalez M et al. Measurement of general health status of non-oxygen-dependent chronic obstructive pulmonary disease patients. Med Care 1992; 30: 125-135.
12. Arnold R, Ranchor AV, DeJongste M et al. The relationship between self-efficacy and self-reported physical functioning In chronic obstructive pulmonary disease and chronic heart failure. Behav Med 2005; 31: 107-115. (Pubitemid 41476568)
13. Terwee C, Wakelkamp I, Tan S et al. Long-term effects of Grave's ophthalmopathy on heath-related quality of life. Eur J Endocrinol 2002; 146: 751-757. (Pubitemid 34705066)
14. Ljunggren AG, Torring O, Wallin G et al. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid 1998; 8: 653-659. (Pubitemid 28405151)
15. Terwee CB, Gerding MN, Dekker FW et al. Development of a disease specific quality of life questionnaire for patients with Graves' ophtalmopathy: the GO-QOL. Br J Ophtalmol 1998; 82: 773-779. (Pubitemid 28376907)
16. Kaahaly GJ, Hardt J, Petrak F et al. Psychosocial factors in subjects with thyroid-associated ophtalmopathy. Thyroid 2002; 12: 237-239. (Pubitemid 34259806)
17. Tehrani M, Krummenauer F, Mann WJ et al. Disease-specific assessment of quality of life after decompression surgery for Graves' ophthalmopthy Eur J Ophthalmol 2004; 14: 193-199.
18. Prummel MF, Terwee CB, Gerling MN et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves' ophthalmopathy. J Clin Endocrinol Metab 2004; 1: 15-20.